ConjuChem Biotechnologies Inc.   Report issue

For profit Phase 2
Founded: Los Angeles CA United States (1997)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2005
NCT00267527
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

ConjuChem

Active Ingredients

Drugs in Phase 2 Trials (2)

cjc 1295 (1 trial)

metformin (glucophage) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Obesity (Phase 2)

Obesity, Abdominal (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 2